Materia Medica is a monthly newsletter published by the University of Colorado's Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Clinical Pharmacy. The primary objective of the newsletter is to educate health care professionals by providing focused reviews of new drug approvals and updates on the pharmacologic management of common disease states. The newsletter is directed towards primary care practitioners, including primarily physicians and pharmacists. Since its inception in 2012, Materia Medica has been written by fourth year pharmacy students while on their Ambulatory Care rotation at Internal Medicine Anschutz or Internal Medicine Lowry.
Materia Medica is edited by Steven M. Smith, PharmD, MPH and Katy Trinkley, PharmD
To subscribe to Materia Medica, send an email request to Materia.Medica@ucdenver.edu.
Issues
Volume 1, Issue 12 (May 2013)
· Antiplatelet therapies to prevent thrombosis of recently placed coronary stents
· Clinical pearls of oral contraceptives
Volume 1, Issue 11 (April 2013)
· Benzodiazepine Use and Discontinuation in Patients with Psychiatric Disorders
· Insomnia Management with Non- Benzodiazepine Sedative Hypnotics in the Primary Care Setting
Volume 1, Issue 10 (March 2013)
· Acute bacterial rhinosinusitis: Applying the 2012 IDSA Clinical Practice Guidelines
· Metformin: Optimal dosing and myths surrounding lactic acidosis
Volume 1, Issue 9 (February 2013)
· Mirabegron: A Novel Treatment for Overactive Bladder
· Risks of NSAIDs and NSAID Use in High-Risk Patients
Volume 1, Issue 8 (January 2013)
· Bipolar Disorder: Medication Management in Primary Care
· Aclidinium Bromide (Tudorza Pressair®): A Novel Long-Acting Antimuscarinic for COPD
Volume 1, Issue 7 (December 2012)
· Lorcaserin: A Novel Weight-Loss Agent
· Probiotics for the Prevention of Antibiotic Associated Diarrhea in Adult Patients
Volume 1, Issue 6 (November 2012)
· Pain Treatment with Opioids in the Primary Care Setting
· Azilsartan medoxomil/Chlorthalidone in Patients with Hypertension
Volume 1, Issue 5 (October 2012)
· Fidaxomicin: A new oral macrolide antibiotic for treatment of Clostridium difficile-associated diarrhea
· Timing of warfarin monitoring and efficacy of vitamin K as a reversal agent
Volume 1, Issue 4 (September 2012)
· Phentermine/Topiramate (Qsymia®) for the treatment of obesity
· Practice considerations for 2nd generation sulfonylureas
Volume 1, Issue 3 (August 2012)
· Lingaliptin (Tradjenta®): A New DPP-4 Inhibitor for Type 2 Diabetes
· Statin Therapy to Achieve Cholesterol and Non-cholesterol Goals of Decreased Morbidity and Mortality
Volume 1, Issue 2 (July 2012)
· The Pioglitazone Controversy: Practice Implications
· Bydureon®: A New Once-Weekly GLP-1 Agonist for Type 2 DM
Volume 1, Issue 1 (June 2012)
· The Use of Rivaroxaban in Nonvalvular Atrial Fibrillation